Neil R. Malhotra, MD

Articles by Neil R. Malhotra, MD

Predictive Index for 90-Day Postoperative Outcomes Following Gynecologic Surgery

ByGregory Glauser, MBA,Eric Winter, BS,Ian F. Caplan, BS,Stephen Goodrich, BS,Scott D. McClintock, PhD,Sindhu K. Srinivas, MD, MSCE,Neil R. Malhotra, MD

July 10th 2020

Increasing LACE+ index score is a significant predictor of greater risk of unplanned readmission, emergency department visits, and reoperation after gynecologic surgery.

LACE+ Index as a Predictor of 90-Day Plastic Surgery Outcomes

ByEric Winter, BS,Gregory Glauser, BS,Ian F. Caplan, BS,Stephen Goodrich, BS,Scott D. McClintock, PhD,Stephen J. Kovach III, MD,Joshua Fosnot, MD,Joseph M. Serletti, MD,Neil R. Malhotra, MD

April 9th 2020

Patients with higher LACE+ index scores have significantly greater risk of unplanned readmission, emergency department visits, and reoperation after plastic surgery.

Latest Updated Articles

LACE+ Index as a Predictor of 90-Day Plastic Surgery Outcomes
Published: April 9th 2020 | Updated:
Predictive Index for 90-Day Postoperative Outcomes Following Gynecologic Surgery
Published: July 10th 2020 | Updated:

Neil R. Malhotra, MD

Articles by Neil R. Malhotra, MD

Predictive Index for 90-Day Postoperative Outcomes Following Gynecologic Surgery

LACE+ Index as a Predictor of 90-Day Plastic Surgery Outcomes

Latest Updated Articles

Trending on AJMC

IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?

FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma

FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause

Eliminating Cost Sharing Boosted Follow-Up Colonoscopy Rates

Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD